Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS)

Juliana C N Chan, Juan Jose Gagliardino, Sei Hyun Baik, Jean-Marc Chantelot, Sandra R G Ferreira, Nicolae Hancu, Hasan Ilkova, Ambady Ramachandran, Pablo Aschner, IDMPS Investigators, Juliana C N Chan, Juan Jose Gagliardino, Sei Hyun Baik, Jean-Marc Chantelot, Sandra R G Ferreira, Nicolae Hancu, Hasan Ilkova, Ambady Ramachandran, Pablo Aschner, IDMPS Investigators

Abstract

Objective: The International Diabetes Mellitus Practice Study is a 5-year survey documenting changes in diabetes treatment practice in developing regions.

Research design and methods: Logistic regression analysis was used to identify factors for achieving A1C <7% in 11,799 patients (1,898 type 1 diabetic and 9,901 type 2 diabetic) recruited by 937 physicians from 17 countries in Eastern Europe (n = 3,519), Asia (n = 5,888), Latin America (n = 2,116), and Africa (n = 276).

Results: Twenty-two percent of type 1 diabetic and 36% of type 2 diabetic patients never had A1C measurements. In those with values for A1C, blood pressure, and LDL cholesterol, 7.5% of type 1 diabetic (n = 696) and 3.6% of type 2 diabetic (n = 3,896) patients attained all three recommended targets (blood pressure <130/80 mmHg, LDL cholesterol <100 mg/dl, and A1C <7%). Self-monitoring of blood glucose was the only predictor for achieving the A1C goal in type 1 diabetes (odds ratios: Asia 2.24, Latin America 3.55, and Eastern Europe 2.42). In type 2 diabetes, short disease duration (Asia 0.97, Latin America 0.97, and Eastern Europe 0.82) and treatment with few oral glucose-lowering drugs (Asia 0.64, Latin America 0.76, and Eastern Europe 0.62) were predictors. Other region-specific factors included lack of microvascular complications and old age in Latin America and Asia; health insurance coverage and specialist care in Latin America; lack of obesity and self-adjustment of insulin dosages in Asia; and training by a diabetes educator, self-monitoring of blood glucose in patients who self-adjusted insulin, and lack of macrovascular complications in Eastern Europe.

Conclusions: In developing countries, factors pertinent to patients, doctors, and health care systems all impact on glycemic control.

Figures

Figure 1
Figure 1
Predictive factors for attaining A1C

Figure 2

Predictive factors for attaining A1C…

Figure 2

Predictive factors for attaining A1C

Figure 2
Predictive factors for attaining A1C

Figure 3

Predictive factors for attaining A1C…

Figure 3

Predictive factors for attaining A1C

Figure 3
Predictive factors for attaining A1C
Similar articles
Cited by
References
    1. Gaede P, Lund-Andersen H, Parving HH, et al.: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591, 2008 - PubMed
    1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993 - PubMed
    1. UK Prospective Diabetes Study: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998 - PubMed
    1. Grol R, Grimshaw J: From best evidence to best practice: effective implementation of change in patients’ care. Lancet 362:1225–1230, 2003 - PubMed
    1. Narayan KMV, Gregg EW, Engelgau MM, et al.: Translation research for chronic diseases: the case for diabetes. Diabetes Care 23:1794–1798, 2000 - PubMed
Show all 16 references
Publication types
MeSH terms
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 2
Figure 2
Predictive factors for attaining A1C

Figure 3

Predictive factors for attaining A1C…

Figure 3

Predictive factors for attaining A1C

Figure 3
Predictive factors for attaining A1C
Similar articles
Cited by
References
    1. Gaede P, Lund-Andersen H, Parving HH, et al.: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591, 2008 - PubMed
    1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993 - PubMed
    1. UK Prospective Diabetes Study: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998 - PubMed
    1. Grol R, Grimshaw J: From best evidence to best practice: effective implementation of change in patients’ care. Lancet 362:1225–1230, 2003 - PubMed
    1. Narayan KMV, Gregg EW, Engelgau MM, et al.: Translation research for chronic diseases: the case for diabetes. Diabetes Care 23:1794–1798, 2000 - PubMed
Show all 16 references
Publication types
MeSH terms
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 3
Figure 3
Predictive factors for attaining A1C

References

    1. Gaede P, Lund-Andersen H, Parving HH, et al.: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591, 2008
    1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993
    1. UK Prospective Diabetes Study: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998
    1. Grol R, Grimshaw J: From best evidence to best practice: effective implementation of change in patients’ care. Lancet 362:1225–1230, 2003
    1. Narayan KMV, Gregg EW, Engelgau MM, et al.: Translation research for chronic diseases: the case for diabetes. Diabetes Care 23:1794–1798, 2000
    1. International Diabetes Federation: Diabetes Atlas. 3rd ed.. Brussels, Belgium, International Diabetes Federation, 2006
    1. von Elm E, Altman DG, Egger M, et al.: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808, 2007
    1. American Diabetes Association: Summary of revisions for the 2007 clinical practice recommendations. Diabetes Care 30(Suppl. 1):S3–S4, 2007
    1. Grant RW, Buse JB, Meigs JB: Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 28:337–442, 2005
    1. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al.: Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diabetes Care 30:496–502, 2007
    1. Eliasson B, Eeg-Olofsson K, Cederholm J, et al.: Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabete Metab 33:269–276, 2007
    1. Saaddine JB, Cadwell B, Gregg EW, et al.: Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 144:465–474, 2006
    1. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002
    1. Schwarzer R: Social-cognitive factors in changing health-related behaviors. Curr Dir Psychol Sci 10:47–51, 2001
    1. Boyko EJ, Fujimoto WY, Leonetti DL, et al.: Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23:465–471, 2000
    1. Farrell D, Henke NP, Mango PD: Universal principles for health care reform. The McKinsey Quarterly 87–97, 2007

Source: PubMed

3
Sottoscrivi